An Integrated Analysis of the Role of Gut Microbiome-Associated Metabolites in the Detection of MASH-Related Cirrhosis
This study identified that gut microbiota and metabolites are associated with MASH-related metabolic dysfunction. LA and Prevotella are depleted during MASH progression, and additional supplementation with Prevotella may be a potential strategy for the future treatment of MAFLD.
Authors
- Yuyong Jiang (ORCID: https://orcid.org/0000-0002-6082-1180)
- Tong Wu (ORCID: https://orcid.org/0000-0002-6983-4172)
- Peipei Meng (ORCID: https://orcid.org/0000-0003-0327-6099)
- Yang Zhou (ORCID: https://orcid.org/0000-0001-6094-073X)
- Xuejie Zhang (ORCID: https://orcid.org/0000-0002-4029-7000)
- Xiaomin Ji
- Feixiang Xiong
- Yixin Hou
- Jialiang Chen (ORCID: https://orcid.org/0009-0009-1674-7954)
Institutions
- Capital Medical University (CN)
- Beijing Ditan Hospital (CN)
Publication Details
- Journal
- Metabolites
- Published
- 2024-12-04
- DOI
- https://doi.org/10.3390/metabo14120681
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77